KD Logo

Conmed Corp.’s latest rating changes from various analysts

Conmed Corp.’s filing revealed that its Director Schwarzentraub Barbara J acquired Company’s shares for reported $99873.0 on May 08 ’24. In the deal valued at $69.26 per share,1,442 shares were bought. As a result of this transaction, Schwarzentraub Barbara J now holds 1,442 shares worth roughly $0.1 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Aronson Martha Goldberg bought 2,000 shares, generating $141,960 in total proceeds. Upon buying the shares at $70.98, the Director now owns 2,000 shares.

Before that, Beyer Pat bought 3,000 shares. Conmed Corp. shares valued at $204,900 were divested by the Chief Operating Officer at a price of $68.30 per share. As a result of the transaction, Beyer Pat now holds 10,807 shares, worth roughly $0.79 million.

Needham reiterated its Conmed Corp. [CNMD] rating to a Buy in a research note published on February 01, 2024; the price target was $129. A number of analysts have revised their coverage, including CL King’s analysts, who began to cover the stock in late May with a ‘”a Buy”‘ rating. KeyBanc Capital Markets also remained covering CNMD and has increased its forecast on March 27, 2023 with a “an Overweight” recommendation from previously “Sector weight” rating. Wells Fargo started covering the stock on March 21, 2023. It rated CNMD as “an Equal weight”.

Price Performance Review of CNMD

On Monday, Conmed Corp. [NYSE:CNMD] saw its stock jump 2.30% to $72.80. Over the last five days, the stock has gained 2.90%. Conmed Corp. shares have fallen nearly -33.52% since the year began. Nevertheless, the stocks have fallen -40.43% over the past one year. While a 52-week high of $138.47 was reached on 01/12/24, a 52-week low of $61.05 was recorded on 04/25/24. SMA at 50 days reached $75.76, while 200 days put it at $95.57. A total of 0.51 million shares were traded, compared to the trading of 0.32 million shares in the previous session.

Levels Of Support And Resistance For CNMD Stock

The 24-hour chart illustrates a support level at 71.56, which if violated will result in even more drops to 70.32. On the upside, there is a resistance level at 73.89. A further resistance level may holdings at 74.99. The Relative Strength Index (RSI) on the 14-day chart is 51.27, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.20, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 7.44%. Stochastics %K at 83.81% indicates the stock is a selling.

The most recent change occurred on October 12, 2022 when Jefferies began covering the stock and recommended ‘”a Hold”‘ rating along with a $85 price target.

Most Popular